Get started
Author

Maya Kansara

Translational biology of osteosarcoma
2014 · Maya Kansara, Michele W. Teng, et al. · Nature reviews. Cancer · 1,290
Molecular Pathogenesis of Osteosarcoma
2007 · Maya Kansara, David M. Thomas · DNA and Cell Biology · 273
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
2009 · Maya Kansara, Michael Tsang, et al. · Journal of Clinical Investigation · 272
PDF
Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensing
2024 · Fei Deng, Yi Li, et al. · Nature Communications · 157
PDF
Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor κB
2005 · Teresa Morgan, Gerald J. Atkins, et al. · American Journal Of Pathology · 132
PDF
Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer
2013 · Dariush Etemadmoghadam, George Au-Yeung, et al. · Clinical Cancer Research · 117
Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
2010 · Dariush Etemadmoghadam, Joshy George, et al. · PLoS ONE · 105
PDF
Acute regulation of glucose transport in a monocyte–macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst
1997 · Nuzhat AHMED, Maya KANSARA, et al. · Biochemical Journal · 80
PDF
An In vivo Tumor Model Exploiting Metabolic Response as a Biomarker for Targeted Drug Development
2005 · Carleen Cullinane, Donna S. Dorow, et al. · Cancer Research · 79
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation
2013 · Maya Kansara, Huei San Leong, et al. · Journal of Clinical Investigation · 77
Epigenetic modifications in osteogenic differentiation and transformation
2006 · David Thomas, Maya Kansara · Journal of Cellular Biochemistry · 61
Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23
2019 · Maya Kansara, Kristian Thomson, et al. · Cancer Discovery · 51
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
2023 · Mandy L. Ballinger, Swetansu Pattnaik, et al. · Science · 50
CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function
1996 · M V Berridge, A S Tan, et al. · The Journal of Immunology · 48
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells
2013 · Jason E. Cain, Andrew McCaw, et al. · Sarcoma · 33
PDF
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism
2024 · Elysse C. Filipe, Sipiththa Velayuthar, et al. · Advanced Science · 28
Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab
2022 · Maya Kansara, Neeru Bhardwaj, et al. · Molecular Oncology · 19
PDF
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations
2023 · Subotheni Thavaneswaran, Maya Kansara, et al. · British Journal of Cancer · 18
PDF
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology
2021 · Frank P. Lin, Subotheni Thavaneswaran, et al. · npj Precision Oncology · 15
PDF
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma
2012 · Christophe Paget, Helene Duret, et al. · OncoImmunology · 14
PDF
Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation.
2004 · Maya Kansara, Michael V Berridge · PubMed · 9
Genomic Therapy Matching in Rare and Refractory Cancers
2026 · Frank P. Lin, Subotheni Thavaneswaran, et al. · JAMA Oncology · 8
PDF
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
2023 · Vijesh G. Vaghjiani, Catherine R. Cochrane, et al. · Oncogene · 8
PDF
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
2024 · Subotheni Thavaneswaran, Frank Lin, et al. · npj Precision Oncology · 7
PDF
RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma
2014 · Maya Kansara, David M Thomas · OncoImmunology · 6
PDF
Works count: 71
Citation count: 2,979
H-index: 18
I10-index: 20
Year
Topic
Type